E3 Ligase and Target Protein Products
Protein Degraderss
degrade the disease-causing proteins by hijacking the ubiquitin-proteasome
system (UPS). Unlike traditional small-molecule inhibitors, Protein Degraderss provide a better
and more efficient strategy. During the discovery process of an efficient
Protein Degraders molecule, multiple parameters and details need to be optimized and
designed, such as the affinity of Protein Degraders molecules to target proteins and to
the E3 ligase proteins. Besides, although there are nearly 600 ligases
identified in the human genome, many of them remain relatively uncharacterized.
To reveal their substrates, in vitro high-throughput
screening with purified E3 ligase is an approach. To make it possibly easier to
fulfill the optimization and the characterization, Creative Biolabs produces several
proteins including E3 ligases and target proteins as products.
Our services are For Research Use Only. We do not provide direct services for patients.
Type: Target protein
Size: 0.1 mg
Expression Length(a.a): 49-460
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 213
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 442
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 491
Type: Target protein
Size: 0.1 mg
Expression Length(a.a): 490
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 497
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 618
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 604
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 142
Type: Target protein
Size: 0.1 mg
Expression Length(a.a): 707
Type: Target protein
Size: 0.1 mg
Expression Length(a.a): 605
Type: Target protein
Size: 0.1 mg
Expression Length(a.a): 542
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 624
Type: Target protein
Size: 0.1 mg
Expression Length(a.a): 374
Type: E3 ligase protein
Size: 0.1 mg
Expression Length(a.a): 190
Datasheet